Breaking News, Promotions & Moves

Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer

Schetter has a proven track record across the entire biopharmaceutical value chain.

Author Image

By: Charlie Sternberg

Associate Editor

Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has appointed Dr. Christian Schetter, Ph.D. as chief scientific officer (CSO) of Rentschler Biopharma SE, where he will be responsible for process technology and innovation, effective 15 September 2021. In this position, he will be working with a team of experienced scientists to ensure Rentschler Biopharma’s continued technological and scientific leadership in process developm...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters